Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The only "official" employee, Bosch, is the youngest. Can't make it up.
100%.
Imagine a CEO who takes 20 years to develop a single treatment in a single cancer knowing the likelihood of some other effective treatment taking the lead, and she has no backup plan for shareholders...Well, at least she had one or two for herself.
Now, as fate would have it, GBM still has no good treatments, but LP could not have known that. And, in just the last few years, as management was trying to get from data lock to submission, a whole new crop of intriguing therapies has arrived to compete.
The army of disciples here is just too great to overcome. No matter how many times one refutes their claims, they always pop back up unfazed by logic and reasoning.
Which investors is the real question? Just like they protected retail investors with the 1.3 billion shares now outstanding. Or maybe how they protected retail investors with the private CDMO's. Come on, Flip, isn't it time to start thinking out of the box? Ask yourself, what would insider selling (and buying for that matter) interfere with that they NEVER did either. Malik sold a 500k and the stock lost half its value.
Flip displaying his interest in investing and concern for fellow investors. Now that is funny!
Had never seen that before until I came across NWBO. I didn't even think that was allowed except maybe for a very special reason, but it's routine with this bunch.
That's how you lost so much cash the last time.
Are you really going to try this again without wearing a bigger skeptics hat to save you from the shining sun?
Or they could just shut it down with no more communication like with AlloVir.
>>We should have data from the MT-601 trial within that timeframe so they'll probably do a raise on the back of that data should it be good enough to warrant an increase in share price.
Yep, you're ignoring me. It could mean they know they have nothing and want to avoid a lawsuit by closing those lending programs. Instead they'll just survive on poor retail. Could also mean they're heading for the OTC (Surprised it hasn't happened already) where the capital raise comes with a very different agreement.
>>Cancelling their ATM certainly was interesting. Especially after previously terminating their deal with Lincoln Park Capital, which should have never been entered into in the first place. These events seem to point to their belief that they either won't have a problem raising capital in the future or won't need to.
Vera seems to be in hiding. There's always the third option which is to string it along while collecting nice salaries.
>>I don't see them making it to market by themselves nor do I have the faith in management that they actually could. The reality is that if the data is underwhelming, they completely fail, or the data continues to show improved results and big pharma buys them out. I dont see anything in between.
It's what they do best...Let enough time go by so green retail forget all the information comes from the disciples and not the company.
But they have not mentioned if MHRA is waiting for LP to catch up with NICE before they get serious about it.
You're here as an "Adviser"? Can't make it up.
Yup, it's all pretty obvious.
>>As for your claims Les Lied, well, if you actually were a shareholder and believed that and had facts to prove it in a legally relevant manner, I am sure you’d have filed suit. Yet here you are, just a blowhard on bulletin boards, 24-7-365, never believably disclosing what your interest is…
Since no share price increase my best guesses are some pre arranged sale of gifted options or a PIPE, or both.
If you knew his record you wouldn't be thanking him. LOL
Hey, how's LP's "mundane" new hirings going, do you think we'll see an employee /C-suite increase in the next filling since they're not sending out PR's? That CEO on the BBS said he's getting overqualified people because biotech is currently in a lull.
How many times have you disciples had to brush yourselves off at this point? LOL
Haha! Les always figures out a way to let shareholders know when to expect something when it can't happen, and when not to expect anything when it's expected. I'm waiting for the "Early 2025" line in his next BBS appearance.
Just have to say how hilarious that an unknown "Investment banker" dude comes on the BBS and is crowned a "NWBO rep" without any NWBO management being there to make the announcement. Then zero communication from the company on the subject and with almost no interest by the disciples here.
Disciples try to assure investors here live in an information vacuum. Skeptics want them to have the information and decide for themselves.
>>The directors formed a special committee in late March to explore potential paths forward.
Wojcicki submitted a proposal to take the company private in July, but it was rejected by the special committee, in part because it didn't provide a premium to the closing price of 40 cents per share at the time.
In a letter to Wojcicki on Tuesday, the directors said they had yet to see a "fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders." The directors said they disagree with Wojcicki about the "strategic direction for the company," so they decided to resign effective immediately.
As a shareholder are you taking any action?
My endgame guesses:
Continue on with small raises forever- 10% chance
Large PIPE for new trial 20% chance
Take NWBO private - 30% chance
Restructure with reverse merge - 40% chance
With LP constantly talking manipulation and unvalued assets it wouldn't surprise me one bit if she tries to take NWBO private. And, I suspect the BOD wouldn't put up a fight like these guys. 23andMe lost its shares holders 99% too.
https://www.cnbc.com/amp/2024/09/17/23andme-independent-directors-resign-from-board-read-the-ceo-memo.html
More dead-end dot connecting. LOL.
I'm curious, that BBS "Investment banker" guy a while back told everyone NWBO was "De-risked" so why hasn't he bought in yet even at 30 cents?
You don't sweat the small stuff because most of it never occurs to you. LOL. How long have you been doing this, a year?
You mean to say the pumping disciple leading the flock can't afford an iHub membership? Did I read that right?
Yes, and that "NWBO rep guy / Investment banker guy" does PIPE's.
They already said on the BBS that they'd try to crater the stock pre PIPE financing.
>>Our deep dip in price
Btw, at the very end of the Tempest Therapeutics BBS interview the CEO (yes, that's right the CEO) says no compassionate use when going for Plll FDA approval.
Ugh...Had to watch it again.
08/26/24- Big Biz Show- Howie Font, Gold Royalty Corp., My Patriot Supply, & Mike Taylor
"They're trying to get the FDA to approve what they're doing"
BBS guy 38:07
BBS guy talking about "Whacking that thing" to get the PIPE at the cheapest price possible. Lots of nervous laughter.
42:00.
I thought the part where the BBS guy was straining to convince himself and the others they're getting closer, like waking from a bad dream, was pretty funny. And, the part where that new NWBO rep guy doesn't bother to correct the BBS guy about swapping MHRA for FDA approval. Oh, and the "Derisked" part was great too. THE SHOW MUST CONTINUE!
Really have to wonder why such a program that so heavily targets retail never asks Les why the company's website still says L is in a Plll? Can't make it up.
That'd help. If it were one long interview they're coming awfully close to that material information release issue. It's baffling the SEC allows it.
Maybe Les thinks he's so old they won't go after him similar to what Hur said about Joe. ??
Well, it has the safety profile, I'll give you that. Maybe a little too safe, if you catch my drift?? Efficacy, on the other hand, is yet to be determined to the satisfaction of many.
I suspect it'll be the same story with L. The disciple army has already paved the way for the PolyICLC story next up.
That BigBizShow show guy said Les was coming on "next week" so whatever happened to that appearance? Or is it just one long interview sliced and diced out of order?
Article receives the disciple IGNORE seal.
So now we know "GoodGuy" doesn't sweat it because he's already resigned to losing everything. Got that, investors?
Tell us, Bill, what were the important issues that weren't first the "unimportant issues" that have legacy shareholders down 99.X% of their hard earned money fifteen years later?
>>posting nonsense about relatively unimportant issues everyday is crazy... But I am delusional?
I know that AloVir abruptly pulled the plug on everything leaving their shareholders devastated. TapImmune would've done the same had they not been smart enough to get bought by Marker. Marker pulled the plug on Tap's experimental products. And, Marker appears to be pulling the plug on some T trials. Not great, and I know Vera was involved in all of it in some way or another. He's not instilling great confidence so far. Hope I'm wrong.
LL is one women. I see no presentations, no literature, no doctrines, no anything on freezing GBM tumors on any scale.
Totally delusional. What do you think retail shareholders, does your wallet reflect the "Catbird seat" claim?
>>NWBO is in the cat-bird's seat. DCVax-L is more efficacious that any cancer treatment on the horizon.